F/M Emerald Life Sciences Innovation ETF (LFSC) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
F/M Emerald Life Sciences Innovation ETF (LFSC) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $103.4M, listed on NASDAQ, carrying a beta of 1.09 to the broader market. LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. public since 2024-10-21.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for LFSC as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.